secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001213900-25-059004
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics receives Nasdaq minimum bid price non-compliance notice
-----------------------------------------------------------------------------

- Nasdaq notified company on June 23, 2025 that common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until December 22, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, company may qualify for an additional 180-day period if it meets other listing requirements and intends to effect a reverse stock split.
- Company is evaluating options; notice does not affect business operations or SEC reporting obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390025059004/0001213900-25-059004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390025059004/ea0246913-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-059004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer